Streetbeat News

Products Services

CLSD

Clearside Biomedical's investigational drug CLS-AX for wet AMD achieved primary and secondary goals in a Phase 2b trial, showing stable visual acuity and anatomy with a well-tolerated safety profile. The trial results support the design of a planned Phase 3 program.

Portfolio Pulse from Vandana Singh

October 09, 2024 | 2:22 pm

CRLBF

MSOS

Cresco Labs CEO Charlie Bachtell emphasized the company's focus on preparing for significant opportunities in 2024, particularly in states like Ohio, Florida, and Pennsylvania, which are moving towards adult-use cannabis legalization.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:22 pm

NIO

NIO Inc's stock has dropped 10% this week due to volatility in Chinese stocks, driven by disappointment over the lack of aggressive fiscal stimulus from Beijing. The Hang Seng Index's significant drop has raised concerns about consumer demand for electric vehicles in China, a key market for NIO.

Portfolio Pulse from Henry Khederian

October 09, 2024 | 2:17 pm

TSLA

Tesla Inc (NASDAQ:TSLA) is in focus as it prepares for its robotaxi event, following record shipments in China. Despite strong deliveries, Tesla's Q3 total fell short of some expectations. Analysts anticipate significant updates at the event, which could drive future growth.

Portfolio Pulse from Adam Eckert

October 09, 2024 | 2:17 pm

CRLBF

MSOS

Charlie Bachtell delivered a keynote at Benzinga's Cannabis Capital Conference, which could impact companies like Cresco Labs (CRLBF) and the AdvisorShares Pure US Cannabis ETF (MSOS).

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:16 pm

BYND

McDonald's France has launched Veggie McPlant Nuggets, a plant-based product developed in collaboration with Beyond Meat. This launch could potentially boost Beyond Meat's market presence in Europe.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:12 pm

VKTX

Viking Therapeutics released positive Phase 1b trial results for VK0214, a drug for X-linked adrenoleukodystrophy (X-ALD), showing safety and efficacy in reducing disease biomarkers. This development could expand Viking's revenue streams into the rare disease market.

Portfolio Pulse from Vandana Singh

October 09, 2024 | 2:11 pm

AMZN

RIVN

Amazon plans to deploy 1,000 electric delivery vans from Rivian by early 2025, featuring vision-assisted package retrieval and internal lighting to guide deliverers to the correct packages.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:07 pm

AMZN

Amazon has introduced AI-powered shopping guides on its main site, aiming to assist users in selecting products from new categories. This move is part of Amazon's strategy to enhance user experience and streamline the shopping process.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:06 pm

USDC

VanEck has launched a $30 million early-stage fund, VanEck Ventures, targeting fintech, digital assets, and AI startups. The fund will focus on pre-seed and seed-stage companies, leveraging VanEck's history of recognizing transformative opportunities. Led by experienced investors Wyatt Lonergan and Juan Lopez, the fund aims to invest in category-defining founders using emerging technologies like blockchain and AI.

Portfolio Pulse from Ivan Crnogatić

October 09, 2024 | 2:04 pm